#johnson-johnson (1 Posts)
-
New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier The FDA has approved Johnson & Johnson's Imaavy for myasthenia gravis, benefiting over 90% of patients and improving daily tasks.
Hot Topics